← FDA Drug Approvals (Drugs@FDA)

OLANZAPINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ASPIRO · Approved 2023-03-22

Drug application

FDA Application #

ANDA217466

Application type

Abbreviated New Drug Application (Generic)

Brand name

OLANZAPINE

Generic name

OLANZAPINE

Active ingredients

OLANZAPINE

Dosage form

POWDER

Route

INTRAMUSCULAR

Marketing status

Prescription

Sponsor

ASPIRO

Manufacturer

Camber Pharmaceuticals, Inc.

First approval

2023-03-22

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown